Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

about

Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

Item

http://www.wikidata.org/entity/Q40160424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

@en

type

Item

label

Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

@en

prefLabel

Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

@en

P1476

Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant

@en

P2093

Ingrid Karlsson

http://www.w3.org/2001/XMLSchema#string

Jens Nielsen

http://www.w3.org/2001/XMLSchema#string

Jim Williams

http://www.w3.org/2001/XMLSchema#string

Marie Borggren

http://www.w3.org/2001/XMLSchema#string

P2860

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

Optimal Use of Vaccines for Control of Influenza A Virus in Swine

DNA vaccines against influenza.

Molecular mechanisms for enhanced DNA vaccine immunogenicity.

Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.

A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.

Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.

Viral vector-based influenza vaccines.

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

P304

1823-1830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1321183

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dennis Christensen

Anders Fomsgaard

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28613978

http://www.w3.org/2001/XMLSchema#string

P932

5557247

http://www.w3.org/2001/XMLSchema#string